Jabbour SA, Fras JP, Hardy E, et al
Orientar a los profesionales sobre las alternativas de tratamiento y recomendaciones para la sustitucin Consumo de aGLP-1 en Sacyl (julio-septiembre 2022) Conclusiones Comentario elaborado por: Alejandra Garca Ortiz (Direccin Tcnica de Farmacia)
His appointment reinforces Nooms position at the center of the next phase of obesity care where medication initiates change, but behavior determines what lasts
research support for Clinical Trials Leadership from Boehringer Ingelheim, Pfizer, AstraZeneca, Novo Nordisk, Esperion, Lilly USA, CSL Behring, and honoraria for consultancy from Lilly USA, Pfizer, Boehringer Ingelheim, Lexicon, Novo Nordisk, Applied Therapeutics, Altimmune, CSL Behring, Bayer, Intercept, New Amsterdam
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child